Drugs / Advair
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02826343 | May 2016 → Jun 2018 | chronic obstructive pulmonary disease | University of Virginia | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00461812 | Apr 2007 → Jan 2010 | asthma | Johns Hopkins University | Terminated | No outcome recorded Stop: Enrollment |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00250341 Comparator | Sep 2005 → Sep 2007 | asthma | Teva Branded Pharmaceutical Products R&D, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Advair | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00461812 ↗ |